Share this page!

I-MAK Profile picture
Twitter logo
14 May, 6 tweets, 4 min read
Need to prepare for next week’s drug pricing hearing with AbbVie? Here’s a thread of four useful resources to read and listen to. ⤵️
“Protect at all costs: how the maker of the world’s bestselling drug keeps prices sky-high”

By @the_sy_guy - @FortuneMagazine
fortune.com/longform/abbvi…
“The never-ending drip of pharmaceutical patents”

By @realtahiramin - @Medium
medium.com/@realtahiramin…
“How AbbVie usurped government regulators and created its own rule of law”

By @OliviaWebbC - Acute Condition
acute.substack.com/p/how-abbvie-u…
“How Big Pharma Keeps Drug Prices High” with @pritikrishtel and @JohnArnoldFndtn

By @NickHanauer and Jasmin Weaver - @PitchforkEcon
pitchforkeconomics.com/episode/how-bi…
Watch "Unsustainable Drug Prices (Part III): Testimony from AbbVie CEO Richard Gonzalez" live on Tuesday, May 18 at 10AM EST.
oversight.house.gov/legislation/he…

• • •

Missing some Tweet in this thread? You can try to force a refresh
　

Keep Current with I-MAK

I-MAK Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @IMAKglobal

I-MAK Profile picture
16 May
Right now, the list price for a year of treatment with Humira is $77k in the U.S. With the availability of biosimilars, the estimated annual price in the EU is $3.5k.

That’s a whopping 22x price difference.

A 🧵 on why the prices for the exact same drug are so different.
AbbVie released Humira in 2002 as an anti-inflammatory treatment.

It raised the price steadily in both the EU & US until 2018, when Humira’s patent protection in Europe ended & biosimilar competitors could enter the market.

The result: W/in 4 months, Humira’s price dropped 70%. Image
However, Americans won't benefit from Humira biosimilars in the marketplace until 2023. That's over 4 years of extended monopoly for Humira in the U.S. vs Europe.

The cost: $70 BILLION that Americans will spend on Humira in that time to line the pockets of AbbVie.
Read 8 tweets

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

Like this author's thread?

Get emails when @IMAKglobal has new unrolls!

Check out other threads from @IMAKglobal!

Read all threads by @IMAKglobal

:(